GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
GYRE THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.09+0.01 (+0.16%)
Close on Oct 19, 2026
- Market cap
- $612.88M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 31, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 8, 2017(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Feb 13, 2017 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Nov 5, 2015(first seen in filings) | 1-for-92 reverse | Earlier per-share figures multiplied by 92 |
| Aug 21, 2015 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |